Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective

Masaharu Kataoka, Takumi Inami, Takashi Kawakami, Keiichi Fukuda, Toru Satoh

Research output: Contribution to journalReview article

Abstract

In recent years, therapeutic options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have expanded with the development of catheter-based interventional therapy, namely balloon pulmonary angioplasty (BPA), also called percutaneous transluminal pulmonary angioplasty. For CTEPH patients with technically inoperable disease or with an unfavorable risk-to-benefit ratio for surgical pulmonary endarterectomy, BPA is an important alternative therapeutic strategy. One important treatment goal of BPA should be the relief of pulmonary hypertension. However, the indications for BPA in specialized Japanese centers currently go beyond the sole indication of relieving pulmonary hypertension. BPA is currently limited to specific institutes and experienced operators, which allows better management of its associated complications of reperfusion pulmonary edema and vascular injury using various strategies based on past experiences. This article discusses the latest indications and treatment goals of BPA and the current flow diagram for therapeutic decision-making in CTEPH, and summarizes the factors to be considered when performing BPA, from a Japanese perspective.

Original languageEnglish
Pages (from-to)1382-1388
Number of pages7
JournalJACC: Cardiovascular Interventions
Volume12
Issue number14
DOIs
Publication statusPublished - 2019 Jul 22

Fingerprint

Balloon Angioplasty
Angioplasty
Pulmonary Hypertension
Lung
Therapeutics
Endarterectomy
Vascular System Injuries
Lung Injury
Pulmonary Edema
Reperfusion
Decision Making
Catheters

Keywords

  • balloon pulmonary angioplasty
  • catheter-based interventional therapy
  • chronic thromboembolic pulmonary hypertension
  • percutaneous transluminal pulmonary angioplasty
  • pulmonary endarterectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension : A Japanese Perspective. / Kataoka, Masaharu; Inami, Takumi; Kawakami, Takashi; Fukuda, Keiichi; Satoh, Toru.

In: JACC: Cardiovascular Interventions, Vol. 12, No. 14, 22.07.2019, p. 1382-1388.

Research output: Contribution to journalReview article

@article{a9b32993dae84c869a05a261a21a3d35,
title = "Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective",
abstract = "In recent years, therapeutic options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have expanded with the development of catheter-based interventional therapy, namely balloon pulmonary angioplasty (BPA), also called percutaneous transluminal pulmonary angioplasty. For CTEPH patients with technically inoperable disease or with an unfavorable risk-to-benefit ratio for surgical pulmonary endarterectomy, BPA is an important alternative therapeutic strategy. One important treatment goal of BPA should be the relief of pulmonary hypertension. However, the indications for BPA in specialized Japanese centers currently go beyond the sole indication of relieving pulmonary hypertension. BPA is currently limited to specific institutes and experienced operators, which allows better management of its associated complications of reperfusion pulmonary edema and vascular injury using various strategies based on past experiences. This article discusses the latest indications and treatment goals of BPA and the current flow diagram for therapeutic decision-making in CTEPH, and summarizes the factors to be considered when performing BPA, from a Japanese perspective.",
keywords = "balloon pulmonary angioplasty, catheter-based interventional therapy, chronic thromboembolic pulmonary hypertension, percutaneous transluminal pulmonary angioplasty, pulmonary endarterectomy",
author = "Masaharu Kataoka and Takumi Inami and Takashi Kawakami and Keiichi Fukuda and Toru Satoh",
year = "2019",
month = "7",
day = "22",
doi = "10.1016/j.jcin.2019.01.237",
language = "English",
volume = "12",
pages = "1382--1388",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "14",

}

TY - JOUR

T1 - Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension

T2 - A Japanese Perspective

AU - Kataoka, Masaharu

AU - Inami, Takumi

AU - Kawakami, Takashi

AU - Fukuda, Keiichi

AU - Satoh, Toru

PY - 2019/7/22

Y1 - 2019/7/22

N2 - In recent years, therapeutic options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have expanded with the development of catheter-based interventional therapy, namely balloon pulmonary angioplasty (BPA), also called percutaneous transluminal pulmonary angioplasty. For CTEPH patients with technically inoperable disease or with an unfavorable risk-to-benefit ratio for surgical pulmonary endarterectomy, BPA is an important alternative therapeutic strategy. One important treatment goal of BPA should be the relief of pulmonary hypertension. However, the indications for BPA in specialized Japanese centers currently go beyond the sole indication of relieving pulmonary hypertension. BPA is currently limited to specific institutes and experienced operators, which allows better management of its associated complications of reperfusion pulmonary edema and vascular injury using various strategies based on past experiences. This article discusses the latest indications and treatment goals of BPA and the current flow diagram for therapeutic decision-making in CTEPH, and summarizes the factors to be considered when performing BPA, from a Japanese perspective.

AB - In recent years, therapeutic options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have expanded with the development of catheter-based interventional therapy, namely balloon pulmonary angioplasty (BPA), also called percutaneous transluminal pulmonary angioplasty. For CTEPH patients with technically inoperable disease or with an unfavorable risk-to-benefit ratio for surgical pulmonary endarterectomy, BPA is an important alternative therapeutic strategy. One important treatment goal of BPA should be the relief of pulmonary hypertension. However, the indications for BPA in specialized Japanese centers currently go beyond the sole indication of relieving pulmonary hypertension. BPA is currently limited to specific institutes and experienced operators, which allows better management of its associated complications of reperfusion pulmonary edema and vascular injury using various strategies based on past experiences. This article discusses the latest indications and treatment goals of BPA and the current flow diagram for therapeutic decision-making in CTEPH, and summarizes the factors to be considered when performing BPA, from a Japanese perspective.

KW - balloon pulmonary angioplasty

KW - catheter-based interventional therapy

KW - chronic thromboembolic pulmonary hypertension

KW - percutaneous transluminal pulmonary angioplasty

KW - pulmonary endarterectomy

UR - http://www.scopus.com/inward/record.url?scp=85068390354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068390354&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2019.01.237

DO - 10.1016/j.jcin.2019.01.237

M3 - Review article

C2 - 31103538

AN - SCOPUS:85068390354

VL - 12

SP - 1382

EP - 1388

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 14

ER -